AGP Executive Report
Last update: 10 hours agoAntimicrobial Resistance & Climate: A new study links climate change to rising antibiotic resistance in Salmonella, showing resistance genes increasing as temperatures and rainfall patterns shift, raising the risk of harder-to-treat infections. Cancer Treatment Signals: Early results from the ERASMM phase 2 study report strong activity for elranatamab in high-risk smoldering multiple myeloma, with high response rates after 6 cycles. Oncology Trial Update: The CHRONO phase 2 trial finds that extending neoadjuvant chemotherapy from 3 to 6 cycles before surgery in advanced high-grade epithelial ovarian cancer does not improve disease-free survival. EU Public Health Response: The EU has sent first batches of experimental Hantavirus antiviral favipiravir to France, Spain and the Netherlands to support treatment under compassionate-use style protocols. Mosquito Control Rethink: Research suggests mosquitoes can learn to associate common repellents like DEET with feeding, helping explain why protection may fail in some situations. Emergency Care & Safety: A French motorcyclist suffered life-changing injuries after a delivery driver failed to see him at a junction, highlighting road-safety risks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
